Form 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934

 

Date of Report: July 28, 2005

Date of earliest event reported: July 28, 2005

 

 

BRISTOL-MYERS SQUIBB COMPANY

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware   1-1136   22-079-0350
(State or Other Jurisdiction
of Incorporation)		   (Commission File Number)   (IRS Employer
Identification Number)

 

345 Park Avenue

New York, NY 10154

(Address of Principal Executive Office)

 

Registrant’s telephone number, including area code: (212) 546-4000

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Item 2.02 Results of Operations and Financial Condition

 

On July 28, 2005, Bristol-Myers Squibb Company issued a press release announcing its financial results for the second quarter of 2005. A copy of the press release is furnished as Exhibit 99.1 to this report and is also incorporated herein by reference. Also furnished and incorporated by reference as Exhibit 99.2 is certain supplemental information posted on the Bristol-Myers Squibb Company’s website at www.bms.com.

 

Item 9.01 Financial Statements and Exhibits

 

(c) Exhibits

 

Exhibit 99.1 – Press release of Bristol-Myers Squibb Company dated July 28, 2005, reporting Bristol-Myers Squibb’s financial results for the second quarter of 2005.

 

Exhibit 99.2 – Certain supplemental information posted on Bristol-Myers Squibb’s website at www.bms.com not included in the press release.

SIGNATURE

 

Under the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the authorized undersigned.

 

BRISTOL-MYERS SQUIBB COMPANY
By:  

/s/ Sandra Leung

    Sandra Leung
Title:   Vice President and Secretary

 

Dated: July 28, 2005

EXHIBIT INDEX

 

Exhibit No.
  

Description

99.1   Press release of Bristol-Myers Squibb Company dated July 28, 2005, reporting Bristol-Myers Squibb’s financial results for the second quarter of 2005.
99.2   Certain supplemental information posted on Bristol-Myers Squibb’s website at www.bms.com not included in the press release.